References to Primary Literature
- HERSY SJ et al.: Gastric acid secretion. Physiol. Rev. (1995) 75:155–189.
- WILDE MI et al.: Omeprazole - an update of its pharmacology and therapeutic use in add-related disorders. Drugs (1994) 48:91–132.
- EKSTROM P et al.: Lansoprazole versus omeprazole Inactive duodenal ulcer disease: A double-blind ran-domised comparative study. Scand. J. Gastroenterol. (1995) 30:210–215.
- BERGLINDH T etal.: Effects of secretogogues on oxygen consumption, aminopyrine accumulation and mor-phology in isolated gastric glands. Acta Physiol. Scand. (1976) 97:401–414.
- PARSONS ME et al.: Properties of the reversible, K* competitive inhibitor of the gastric (11./IR)-ATPase, SK&F 97574. 11 Pharmacological properties. Biochem. Pharmacol. (1995) 50:1551–1556.
- POPE AJ et al.: Reversible enzyme inhibitors of the gastric 11./IC - transporting ATPase: A new class of antisecretory agent. Trends Pharmacol. Sci. (1993) 14:323–325.
- POPE AJ et al.: Reversible inhibitors of the gastric (11+/K+)-ATPase as both potential therapeutic agents and probes of pump function_ Biochem. Soc. Trans. (1992) 20:566–571.